- Home
- Companies
- australasia
- disease development
Show results for
Refine by
Industries served
- Medical / Health Care
- Agriculture
- Monitoring and Testing
- Manufacturing, Other
- Chemical & Pharmaceuticals
- Waste and Recycling
- Water and Wastewater
- Health and Safety
- Government
- Food and Beverage
- Energy
- Retail
- Commercial
- Pulp & Paper
- Real Estate
- Maritime/Shipbuild/Water Transport
- Oil, Gas & Refineries
- Environmental
- Soil and Groundwater
- University / Academia / Research
- Construction & Construction Materials
Disease Development Suppliers Serving Australasia
86 companies found
based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. A broader window of opportunity. Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety ...
based inSauerlach, GERMANY
LOEWE was established in 1988 as an independent, privately owned company. As one of the commercial pioneers in the plant disease detection sector, the company started with the distribution of antisera for ELISA detection of plant viruses, produced ...
based inSan Francisco, CALIFORNIA (USA)
Invitae’s mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Like wearing sunscreen or getting your blood pressure checked at the doctor, genetic testing is another important ...
Like wearing sunscreen or getting your blood pressure checked at the doctor, genetic testing is another important tool to help manage your health and lifestyle. Your genes can give you clues into your risk of developing ...
based inGeumcheon-gu, SOUTH KOREA
Since KogeneBiotech was founded in 2000, and our company has earned a reputation for innovation in Molecular Diagnostics. Our main business units are the production of Real-time PCR/conventional assay based on the active R&D works and testing ...
based inCounty of New Castle, DELAWARE (USA)
MedGenome Inc. is a global leader in personalized medicine with unique genomic solutions in immuno-oncology, diabetes, ophthalmology, cardiology and other rare diseases. Founded in 2013, MedGenome currently has a Next Generation Sequencing (NGS) ...
Detailed RNA specific QC reports. Differential expression analysis. Pathway enrichment analysis. Fusion and splicing event analysis with interactive genome browser to visualize results. Proprietary tumor microenvironment ...
based inIllkirch-Graffenstaden, FRANCE
Emosis develops and provides physicians with first-in-class, on demand, and user-friendly extended in vitro diagnostic products, centered on lab assay kits to be routinely performed on the rapidly growing new generation of flow cytometers, including ...
based inGhent/Zwijnaarde, BELGIUM
Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic ...
based inBudapest, HUNGARY
Mediso Medical Imaging Systems with headquarters in Budapest is a dynamic supplier of Nuclear Medicine and modern Hybrid Imaging techniques to the health care and medical research institutions of the world. The company was founded in 1990 by experts ...
The MultiScan™ Large Field of view Extreme Resolution PET/CT system is offering molecular imaging with high spatial resolution and high quantitative accuracy in a gantry that supports all possible non-human primate (NHP) studies. Fine crystal ...
based inBentley DC, AUSTRALIA
Ozgene is one of the leading companies providing genetically modified mice for researchers around the world. We offer a full spectrum of pre-clinical capabilities from the development of mouse models through to breeding, characterisation and ...
These mouse models allow researchers to gain insight into how the loss of the gene affects physiology, behavior and disease development. Observing the characteristics of a knockout phenotype can also help ...
based inGunpo-si, SOUTH KOREA
DxGen is Point-Of-Care (POC) diagnostics company. We provide products for entire stages of diabetes care from initial assessment to post-diagnosis treatment. Our goal is to help make clinical decisions in the care and treatment of patients at the ...
Test Kit is for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control. ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...
based inStaten Island, NEW YORK (USA)
The SensitivE Audit is a health level assessment device that can detect diseases at the early stages, when there are no florid symptoms, and offers the highest accuracy of up to 97%. Thanks to the joint work of physicists, physicians and computer ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed laboratory, Genesys Biolabs (CLIA ...
based inShenzhen, CHINA
LANDWIND MEDICAL is a health care group company headquartered in Shenzhen, China, established in 1994. Till now, we cater our global medical care to over 30,000 medical institutions in more than 130 countries. We integrate our dedicated and ...
Digital Color Doppler Diagnostic Ultrasound System Mirror5 Touch is designed with multiple applications to satisfy different users with varies needs on patient care. Confident in action, guaranteed by Landwind R&D team for performance with ...
based inSint-Denijs Westrem, BELGIUM
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
Liver disease, a large and growing market globally. Cirrhosis is late-stage liver disease which occurs when scar tissue (fibrosis) replaces healthy tissue. Alcohol and viral hepatitis B and C are common causes of cirrhosis, although there are many ...
based inRegensburg, GERMANY
At lifespin, we digitize biological samples. We create the connection of “life” to the possibilities of the information age. We record very many metabolites simultaneously in one measurement and thus create a “fingerprint” of a person or an organism ...
based inNew York, NEW YORK (USA)
miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management ...
based inBengaluru, INDIA
Achira Labs, founded in Bengaluru, India in 2009, is an ISO 13485 compliant microfluidics-based medical diagnostics company at the forefront of developing and commercializing innovative technologies for point-of-care medical testing. Our vision is ...
The ACIX platform developed by Achira represents a significant advancement in point of care diagnostics. Utilizing microfluidics, it integrates a plastic disposable cartridge with dry reagents and a portable reader to deliver ...
based inNeedham, MASSACHUSETTS (USA)
Invicro is an integral part of the REALM IDx, Inc. group, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs. As a global research partner to the ...
Our diverse team of experts have experience in instrument engineering, signal processing, and pharmaceutical R&D, collectively resulting in a long history designing and executing imaging and pathology studies. Our scientists have performed ...
